Key Takeaways
- Domestic engine roars, inventory overhang cleared: India revenue grew 15% with modern trade surging over 100%, while the general trade inventory overhang that suppressed sell-in has fully normalized as of 30 June.
- Overseas bets are polarizing sharply: Bonaire USA grew 35% and GSK China grew 43% with China now debt-free, while CTPL Australia continues to soften and IMPCO Mexico suffered a second consecutive mild summer, a first in 30+ years.
- Margin pressure is coming, magnitude unknown: Raw material costs are "going haywire" and management expects a near-term margin impact it cannot yet quantify, despite planned price hikes and cost reduction efforts.
- Capital efficiency improved dramatically: Standalone core capital employed halved to ₹73 crore and consolidated nearly halved to ₹206 crore after FY26 impairments, with a clear commitment of no further capital allocation to Australia.
- What to watch next quarter: Whether household cooler price hikes land and stick, the pace of general trade recovery now that inventory is clean, and whether Mexico's summer of '27 breaks the two-year mild streak as management bets it statistically must.
Domestic Demand & Channel Dynamics
- Modern trade exploded, but the base effect is real: Growth over 100% was driven partly by the absence of channel inventory that weighed on general trade; management explicitly warned this rate is "very unlikely" to repeat.
- General trade sell-out was strong, sell-in was not: Phenomenal consumer offtake was masked by elevated carry-over inventory from the previous year, so reported general trade revenue understated true demand. That overhang is now gone.
- Inventory fully normalized at season-end: As of 30 June 2026, no inventory overhang remains at either the trade or company level, setting up a clean base for general trade to register growth going forward.
- Digital channels are small but highly profitable: D2C and digital channels carry profitability in excess of the normal domestic business and have "huge potential to scale up," though management declined to disclose their exact sales proportion, while noting modern trade including e-commerce and D2C constitutes in excess of one-third of India topline.
- Q1 demand was patchy by region: North and East India saw uneven demand due to weather patterns, while no secondary sales are expected in the coming quarter, though primary off-season buying by channel partners will occur.
Bakeri: "We cannot expect, this kind of growth, though we will be very happy if, this kind of growth continues. But that's very unlikely to happen. So, I think we shouldn't expect that going forward."
Overseas Subsidiaries: The Tale of Four Markets
| Subsidiary | Trend | Commentary |
|---|---|---|
| Bonaire USA | ▲ Strong growth | Revenue up 35% on successful scale-up of new "Air Force" air-cooler model sold to Home Depot and Lowe's, aided by a very good summer in the US Southwest; revenue will continue into Q2 but then go muted in Q3 and Q4 as coolers are seasonal. |
| GSK China | ▲ Strong growth | Revenue up 43% with operating leverage lifting profitability; now completely debt-free on a standalone basis after repaying all debt plus interest to Symphony India; more even sales cycle due to industrial coolers and exports. |
| IMPCO Mexico | ▼ Weak | Two consecutive mild summers (2025 and 2026) suppressed sales, a pattern people with 30+ years at the company have never seen; management views a third mild summer as statistically almost impossible, so summer of '27 should be robust. |
| CTPL Australia | ▼ Continued softening | EBITDA negative ₹4 crore; PAT inflated by a one-time ₹42 crore gain on sale of Bonaire USA shareholding and IPRs that nets off at the consolidated level; strategy is "just more of the same, nothing new" with no additional capital deployed. |
- US and Australia are structurally different markets: Management noted the two markets have very different breakups, so the US distribution model could not have been applied in Australia even if desired.
- Cooler perception outside India is a structural advantage: In markets like the US and Mexico, coolers are not viewed as a poor man's air conditioner substitute, which supports premium positioning and distinct demand drivers from India.
Shah: "First and foremost, our strategy is not to deploy any additional capital and whatever best can be done without deploying any additional capital in our Australian business. The point is that we are very clear internally and also to assure all the shareholders that whatever impairment or write-off is the history that's not going to happen."
Margins & Cost Pressures
- Gross margin held up despite multiple headwinds: Marginally increased to 49.8% even with geopolitical disruption, commodity price pressure, and the inventory overhang from the bad summer of 2025.
- Raw material costs are the emerging threat: Input costs are described as "going haywire," and while a 7–10% price hike has been taken in other segments, no hike has yet been implemented in the household cooler segment.
- Household cooler price hikes are coming but timing is uncertain: Management will take hikes "in the days to come," with the extent depending on when geopolitical conditions normalize and costs stabilize.
- Near-term margin impact is certain, magnitude is not: Despite value engineering and cost reduction efforts, some margin compression is likely; management cannot yet quantify how much.
- Export markets face a different cost problem: Landed costs have shot up in non-Middle-East export regions and buyers cannot pass on the entire increase, so purchasing remains muted and has not returned to normal.
Bakeri: "So, in the short term, margins are likely to be impacted. ... Despite all the value engineering, despite all the cost reduction that we will be attempting to do, there will be some impact. Difficult to quantify as yet how much, but there is likely to be some impact."
Capital Allocation & Balance Sheet
- Capital employed nearly halved: Standalone core capital employed fell to ₹73 crore from ₹136 crore, and consolidated nearly halved to ₹206 crore from ₹409 crore, driven by the FY26 impairment and CTPL Australia no longer consuming substantial capital.
- Treasury stable after Australia remittance: Stands at ₹345 crore after remitting approximately ₹225 crore to Australia for loan repayments, almost in line with the prior year.
- Australia: no more money, no more write-offs: Management gave an explicit assurance that the FY26 impairment and write-off is history that will not repeat, and the strategy is to do whatever best can be done without additional capital.
- Interim dividend declared: ₹1 per share on a face value of ₹2, implying a total payout of approximately ₹7 crore for Q1 FY27.
Product & Channel Expansion
- BISP products entering general trade: Tabletop fans and water heaters have launched in modern retail and general trade channels across top cities; management says it is "just a matter of time" before they are present everywhere in GT across the country.
- Bonaire USA growth is product-led: The 35% revenue jump is primarily driven by the "Air Force" model, a rebranded Indian SKU sold under the Bonaire brand, scaling successfully at Home Depot and Lowe's, aided by a very good summer in the USA.
- GSK China's cycle is evening out: Industrial coolers and export orders are making the sales cycle more balanced across quarters compared to the US business.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| No further capital to Australia | Zero additional capital deployment; strategy is to optimize without fresh investment | Ongoing |
| General trade growth resumption | General trade and all other trade channels expected to register growth now that inventory is normalized | In line with business plan |
| Household cooler price hikes | Hikes to be taken; extent depends on cost normalization | "In the days to come" |
| Mexico recovery | Summer of '27 statistically almost impossible to be mild; sales should grow significantly | Summer of '27 |
| BISP GT expansion | Tabletop fans and water heaters to be present everywhere in GT across the country | "Just a matter of time" |
| Near-term margin impact | Some margin compression likely; difficult to quantify | Short term |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Consolidated revenue | ₹378 cr, up 8% YoY |
| Consolidated EBITDA | ₹48 cr, up 26% YoY from ₹38 cr |
| Consolidated EBITDA (adjusted) | ₹53 cr, vs ₹38 cr in Q1 FY26, excluding one-time non-cash expenditure of ₹5 cr |
| Consolidated PAT | ₹40 cr, down from ₹42 cr |
| Consolidated PAT (adjusted) | ₹43 cr, up 23% YoY from ₹35 cr, excluding one-offs |
| Consolidated gross margin | 49.8%, marginally increased YoY |
| Consolidated EBITDA margin | 12.6% |
| Standalone revenue | ₹241 cr, vs ₹229 cr |
| Standalone EBITDA | ₹30 cr, vs ₹24 cr |
| Standalone PAT | ₹28 cr, vs ₹37 cr; adjusted ₹28 cr vs ₹24 cr excluding one-offs in both quarters |
| Domestic (India) revenue growth | 15% YoY |
| Modern trade growth | in excess of 100% YoY |
| BISP share of consolidated TTM revenue | ~48%, ~₹560 cr |
| BISP share of standalone TTM revenue | 23%, ₹179 cr |
| Standalone ROCE | 164% |
| Standalone return on net worth | 22% |
| Consolidated ROCE | 67% |
| Consolidated return on net worth | 18% |
| Standalone treasury | ₹345 cr, vs ₹363 cr as of 30 June '26 |
| Consolidated capital employed | ₹206 cr, vs ₹409 cr as of 30 June '26 |
| Standalone core capital employed | ₹73 cr, vs ₹136 cr as of 30 June '26 |
| Bonaire USA revenue | ₹36 cr, up 35% YoY from ₹27 cr |
| Bonaire USA EBITDA | ₹18 cr, vs ₹7 cr; PAT ₹17 cr |
| GSK China revenue | ₹34 cr, up 43% YoY from ₹24 cr |
| GSK China EBITDA | ₹6 cr, vs ₹2 cr; PAT ₹5 cr |
| IMPCO Mexico revenue | ₹54 cr, vs ₹66 cr |
| IMPCO Mexico EBITDA | ₹3 cr, vs ₹7 cr; PAT ₹1 cr |
| CTPL Australia revenue | ₹27 cr, vs ₹31 cr |
| CTPL Australia EBITDA | negative ₹4 cr, vs negative ₹2 cr |
| Interim dividend | ₹1 per share, total payout ~₹7 cr |
| Price hike (ex-household cooler segment) | 7% to 10% |